FR11C0020I2 - Difluoroprostaglandin derivatives and their application - Google Patents

Difluoroprostaglandin derivatives and their application

Info

Publication number
FR11C0020I2
FR11C0020I2 FR11C0020C FR11C0020C FR11C0020I2 FR 11C0020 I2 FR11C0020 I2 FR 11C0020I2 FR 11C0020 C FR11C0020 C FR 11C0020C FR 11C0020 C FR11C0020 C FR 11C0020C FR 11C0020 I2 FR11C0020 I2 FR 11C0020I2
Authority
FR
France
Prior art keywords
application
difluoroprostaglandin
derivatives
difluoroprostaglandin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0020C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27301396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR11C0020(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Publication of FR11C0020I1 publication Critical patent/FR11C0020I1/fr
Application granted granted Critical
Publication of FR11C0020I2 publication Critical patent/FR11C0020I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
FR11C0020C 1996-12-26 2011-06-21 Difluoroprostaglandin derivatives and their application Active FR11C0020I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34861496 1996-12-26
JP7405497 1997-03-26
JP17247797 1997-06-27

Publications (2)

Publication Number Publication Date
FR11C0020I1 FR11C0020I1 (en) 2011-07-29
FR11C0020I2 true FR11C0020I2 (en) 2012-03-16

Family

ID=27301396

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0020C Active FR11C0020I2 (en) 1996-12-26 2011-06-21 Difluoroprostaglandin derivatives and their application

Country Status (16)

Country Link
US (2) US5886035A (en)
EP (1) EP0850926B1 (en)
JP (2) JP3480549B2 (en)
KR (1) KR100526282B1 (en)
CN (1) CN1108289C (en)
AT (1) ATE225770T1 (en)
CA (1) CA2225761C (en)
DE (2) DE69716226T2 (en)
DK (1) DK0850926T3 (en)
ES (1) ES2187719T3 (en)
FR (1) FR11C0020I2 (en)
LU (1) LU91943I2 (en)
NL (1) NL300407I2 (en)
NO (2) NO317060B1 (en)
PT (1) PT850926E (en)
TW (1) TW536534B (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012175A1 (en) * 1996-09-17 1998-03-26 Asahi Glass Company Ltd. Fluorinated prostaglandin derivatives and medicines
US6225348B1 (en) 1998-08-20 2001-05-01 Alfred W. Paulsen Method of treating macular degeneration with a prostaglandin derivative
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
IL134241A (en) 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
AU2001228836A1 (en) * 2000-01-28 2001-08-07 Santen Pharmaceutical Co., Ltd. Novel difluoroprostaglandin derivative
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
DE60316574T2 (en) * 2002-08-23 2008-07-03 Santen Pharmaceutical Co., Ltd STABLE EYE DROPS CONTAINING LATANOPROST AS AN ACTIVE SUBSTANCE
CA2498233C (en) 2002-09-09 2012-08-14 Santen Pharmaceutical Co., Ltd. Clear ophthalmic solution comprising latanoprost as active ingredient
WO2005011704A1 (en) * 2003-07-31 2005-02-10 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
CN102497368A (en) * 2003-12-08 2012-06-13 高通股份有限公司 High data rate interface with improved link synchronization
RU2429849C2 (en) * 2004-12-09 2011-09-27 Сантен Фармасьютикал Ко., Лтд Product containing prostaglandin having fluorine atom in molecule
JP4753178B2 (en) * 2004-12-24 2011-08-24 参天製薬株式会社 Products containing prostaglandin F2α derivatives
JP5100025B2 (en) * 2005-03-31 2012-12-19 旭硝子株式会社 Retinal nerve cell protective agent containing prostaglandin F2α derivative as an active ingredient
US20090234005A1 (en) * 2005-03-31 2009-09-17 Naruhiro Ishida Protective agent for retinal neuronal cell containing prostaglandin f2alpha derivative as active ingredient
EP1870099A4 (en) 2005-04-13 2008-07-16 Ube Industries Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
EP1917239A1 (en) * 2005-06-29 2008-05-07 Pfizer, Inc. Fluoroprostaglandins nitroderivatives
CN102391237B (en) * 2006-02-07 2014-07-16 株式会社·R-技术上野 Method for preparing prostaglandin derivative
WO2007111806A2 (en) 2006-03-23 2007-10-04 Massachusetts Eye And Ear Infirmary Cyclopentane heptanoic acid compounds for reducing body fat
FR2918891B1 (en) * 2007-07-20 2009-09-25 Thea Sa Lab OPHTHALMIC SOLUTION BASED ON PROSTAGLANDINS WITHOUT PRESERVATIVE
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
RU2504380C2 (en) * 2008-09-04 2014-01-20 Сантен Фармасьютикал Ко., Лтд. AGENT PROMOTING HAIR GROWTH CONTAINING 15, 15-DIFLUOROPROSTAGLAN F2α DERIVATIVE AS ACTIVE INGREDIENT
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
AU2010358560B2 (en) 2010-08-02 2015-02-12 Ac Patent Holding Inc. Composition, method and kit for enhancing hair
JP5778781B2 (en) 2011-01-19 2015-09-16 トポカイン セラピューティックス， インコーポレイテッド Methods and compositions for treating metabolic syndrome
TW201906614A (en) 2011-02-04 2019-02-16 日商興和股份有限公司 Eye drops for the prevention or treatment of glaucoma or ocular hypertension
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
WO2013118058A1 (en) * 2012-02-07 2013-08-15 Dr.Reddys Laboratories Limited Amine salts of prostaglandin analogs
CA2874288A1 (en) 2012-05-30 2013-12-05 Asahi Glass Company, Limited Composition for hair growth
CN104936595A (en) 2012-11-21 2015-09-23 托普凯恩制药公司 Methods and compositions for locally increasing body fat
NO2753788T3 (en) 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
CN103570549B (en) * 2013-10-11 2016-01-27 天泽恩源（天津）制药有限公司 A kind of method of synthesizing tafluprost
CN103804195B (en) * 2014-01-26 2016-06-15 天泽恩源（天津）制药有限公司 A kind of method synthesizing tafluprost
CN103819436A (en) * 2014-02-21 2014-05-28 天泽恩源（天津）医药技术有限公司 Crystal form of (3aR,4R,5R,6aS)-4-((E)-3,3-difluoro-4-phenoxylbutyl-1-alkyl-1-yl)-2-oxohexahydro-2H-cyclopentane[b]furan-5-benzoate, and preparation method of corresponding crystals thereof
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
KR20160116402A (en) 2015-03-30 2016-10-10 연성정밀화학(주) Process for Preparing Tafluprost
JP2018536017A (en) 2015-09-22 2018-12-06 グレイバグ ビジョン インコーポレイテッド Compounds and compositions for the treatment of ocular disorders
CN107226790A (en) * 2016-03-25 2017-10-03 苏州朗科生物技术有限公司 A kind of preparation method and midbody compound of high-purity tafluprost and its similar compound
GR1009040B (en) 2016-04-19 2017-05-19 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Preservative free pharmaceutical ophthalmic compositions
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
CN108299192A (en) * 2017-01-10 2018-07-20 江苏恒瑞医药股份有限公司 A kind of metal salt compound crystal form and preparation method thereof of tafluprost acid
CN106986766B (en) * 2017-05-08 2021-01-12 扬子江药业集团有限公司 Preparation method of tafluprost
CN112457277B (en) * 2020-12-16 2022-06-28 西安国康瑞金制药有限公司 Preparation method of tafluprost
CN112832150B (en) * 2021-01-27 2022-06-24 中交第三公路工程局有限公司 Vertical scabbling device for equal vertical surfaces of culvert channels
CN115322095A (en) * 2021-01-27 2022-11-11 Ａｇｃ株式会社 Purification method of tafluprost
CN116120268A (en) * 2023-03-06 2023-05-16 南京华威医药科技集团有限公司 Tafluprost intermediate impurity and preparation method thereof
CN116425707A (en) * 2023-03-31 2023-07-14 南京华威医药科技集团有限公司 Tafluprost intermediate isomer impurity and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166178B1 (en) * 1987-09-18 1998-07-21 R Tech Ueno Ltd Ocular hypotensive agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
JPH0770054A (en) * 1993-08-30 1995-03-14 R Tec Ueno:Kk Biological antagonist and disease-treating preparation
WO1998012175A1 (en) * 1996-09-17 1998-03-26 Asahi Glass Company Ltd. Fluorinated prostaglandin derivatives and medicines
EP0938472B1 (en) * 1996-11-12 2001-06-27 Alcon Laboratories, Inc. 15-fluoro prostaglandins as ocular hypotensives

Also Published As

Publication number Publication date
NO976085L (en) 1998-06-29
CN1108289C (en) 2003-05-14
US5886035A (en) 1999-03-23
ES2187719T3 (en) 2003-06-16
LU91943I2 (en) 2012-04-16
ATE225770T1 (en) 2002-10-15
DK0850926T3 (en) 2003-02-17
NO317060B1 (en) 2004-08-02
NL300407I2 (en) 2010-03-01
NO976085D0 (en) 1997-12-23
CA2225761C (en) 2009-04-21
KR19980064718A (en) 1998-10-07
EP0850926A3 (en) 1999-06-16
DE69716226T2 (en) 2003-06-05
JPH1171344A (en) 1999-03-16
PT850926E (en) 2003-02-28
FR11C0020I1 (en) 2011-07-29
US5985920A (en) 1999-11-16
KR100526282B1 (en) 2006-05-17
CA2225761A1 (en) 1998-06-26
EP0850926A2 (en) 1998-07-01
JP3994074B2 (en) 2007-10-17
NL300407I1 (en) 2009-11-02
NO2009006I2 (en) 2012-03-05
DE69716226D1 (en) 2002-11-14
DE122008000050I2 (en) 2011-06-16
EP0850926B1 (en) 2002-10-09
NO2009006I1 (en) 2009-03-16
DE122008000050I1 (en) 2009-01-29
TW536534B (en) 2003-06-11
JP2004002462A (en) 2004-01-08
CN1187486A (en) 1998-07-15
JP3480549B2 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
FR11C0020I2 (en) Difluoroprostaglandin derivatives and their application
DE69738197D1 (en) AZOLOTRIAZINE AND PYRIMIDINE
FI964298A0 (en) Faestningsanordning Foer baerbar apparat
DE69735712D1 (en) ARYL-PYRIMIDINE DERIVATIVES
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
DE69842210D1 (en) Introducer And Introducer Set
NO981946D0 (en) Imidazoquinazolin derivatives
ID18010A (en) MODIFIED OLIGOSAKARIDA
EE9800378A (en) Alkylaminobenzothiazole and benzoxazole derivatives
DE959898T1 (en) LACTOTRINE VARIANTS AND USES THEREOF
IS5026A (en) 2-methoxyphenylpiperazine derivatives
DK0826679T3 (en) Naphthyl compounds and preparations
FI971376A0 (en) Trofinin and trofininmedlande proteiner
ES1034733Y (en) PERFECTED ASHTRAY
FI944556A0 (en) Foerfarande Foer producering av anthracycliner and deras mellanprodukter
BR9709277A (en) Substituted amidinobenzene derivatives and medicinal compositions thereof
FI962741A0 (en) Sollins and braennpunktsvaermare i kombination med vaermeacumulator
BR7603138U (en) Practical and unique
DE59710718D1 (en) tipping
FI963105A0 (en) Pao anvaendarurval baserad och elsaeker anslutningsdosa and stickpropp
FI974202A0 (en) Anordning and foerfarande Foer tvaettning av smutsiga konstruktioner
FI960008A0 (en) Foerfarande and anordning med vilken en jonproduktionselektrod haolls ren
FI942533A0 (en) Spolvaetska och droppdoseringsfoerpackning Foer contactlins and anvaendning av desamma
FI945616A0 (en) Foerfarande and anordningar Foer utnyttjande av vaogenergi
FI961432A0 (en) Injection and octagment